DTIL Archived Articles
Precision BioSciences (DTIL): A Novel Approach to Gene Editing Unlocking Therapeutic Potential
Published on March 11, 2025
Precision BioSciences Pioneers Next-Generation Gene Editing with ARCUS Platform
Published on November 30, 2024
Precision BioSciences, Inc. (NASDAQ:DTIL): Leveraging ARCUS for Sophisticated Gene Editing Therapies
Published on September 24, 2024